Large-scale testing (Phase 3)Study completedNCT04785326
What this trial is testing
Efficacy, Safety, and Immunogenicity of Subcutaneous DMB-3115 Versus Stelara® in Patients With Moderate to Severe Chronic Plaque Psoriasis
Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Dong-A ST Co., Ltd. 598